South & Central America Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The cranial implants market in South and Central America is projected to grow significantly, reaching approximately US$ 194.20 million by 2031, up from US$ 118.67 million in 2023, with a compound annual growth rate (CAGR) of 6.4% during the forecast period.

Executive Summary and Market Analysis

The market is divided into key regions: Brazil, Argentina, and the Rest of South and Central America. Growth in this sector is driven by several factors, including advancements in healthcare infrastructure, an increasing elderly population, and a rise in neurological disorders. Enhanced healthcare investments and better access to medical services are also pivotal in propelling market growth. Furthermore, heightened awareness among healthcare professionals and patients regarding the advantages of cranial implants is crucial in boosting demand.

Market Segmentation Analysis

The South and Central America cranial implants market can be analyzed through various segments, including type, material, and application:

By Type: The market is categorized into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants held the largest market share.
By Material: The segmentation includes polymethyl methacrylate, polyether ether ketone (PEEK), titanium, and others. PEEK was the leading material in market share in 2023.
By End User: The market is divided into hospitals, trauma centers, and other facilities, with hospitals accounting for the largest share in 2023.

Market Outlook

The advent of 3D printing technology, or additive manufacturing, has revolutionized the production of cranial implants, allowing for highly customized, patient-specific solutions that enhance fit and functionality compared to traditional implants. This technology enables precise replication of individual skull geometries, which minimizes surgical complications and improves recovery outcomes. The integration of multilayer technology in 3D printing further enhances these benefits, allowing for the creation of implants with distinct layers tailored for specific functions, such as structural strength and biocompatibility.

These multilayered 3D-printed implants can improve osseointegration, reduce the likelihood of implant rejection, and provide better protection for the brain. Additionally, 3D printing facilitates faster production times, lower costs, and greater adaptability to complex cranial deformities, making cranial implants more accessible to a wider patient demographic. The advancements in 3D printing technology, particularly with multilayer capabilities, present significant opportunities for growth in the cranial implant market.

Country Insights

The market is primarily composed of Brazil, Argentina, and the Rest of South and Central America, with Brazil leading in market share as of 2023. According to the Pan American Health Organization, Brazil had over 30 million individuals aged 60 and above in 2022, representing 13% of its population. This number is expected to rise to nearly 50 million by 2030, constituting 24% of the total population. The World Health Organization and the Brazilian Institute of Geography and Statistics predict that the geriatric population will reach approximately 55 million by 2040. The aging population correlates with an increase in neurological diseases, thereby driving demand for cranial implants.

As the elderly seek improved treatment options to enhance their quality of life, advancements in cranial implant technology are making these solutions more accessible. A study on traumatic brain injury (TBI) hospital admissions in Brazil indicated an average of 131,014 admissions per year from 2008 to 2019, highlighting the need for protective and reconstructive solutions. Cranial implants are essential for restoring skull integrity and protecting the brain, leading to their increased adoption in clinical settings to improve recovery outcomes for TBI patients.

Company Profiles

Key players in the South and Central America cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative products to consumers.

Product Code: BMIRE00031984

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. South & Central America Cranial Implants Market Landscape

4.1 Overview
4.2 PEST Analysis

5. South & Central America Cranial Implants Market - Key Market Dynamics

5.1 South & Central America Cranial Implants Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Prevalence of Traumatic Brain Injuries
- 5.2.2 Surge in Elderly Populations
5.3 Market Restraints
- 5.3.1 Risk of Implant Failure
5.4 Market Opportunities
- 5.4.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
5.5 Future Trends
- 5.5.1 Customized Implants
5.6 Impact of Drivers and Restraints:

6. South & Central America Cranial Implants Market - Analysis

6.1 South & Central America Cranial Implants Market Revenue (US$ Million), 2021-2031
6.2 South & Central America Cranial Implants Market Forecast Analysis

7. South & Central America Cranial Implants Market Analysis - by Type

7.1 Parietal
- 7.1.1 Overview
- 7.1.2 Parietal: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Frontal
- 7.2.1 Overview
- 7.2.2 Frontal: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Occipital
- 7.3.1 Overview
- 7.3.2 Occipital: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Temporal
- 7.4.1 Overview
- 7.4.2 Temporal: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Sphenoid
- 7.5.1 Overview
- 7.5.2 Sphenoid: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Cranial Implants Market Analysis - by Material

8.1 Polymethyl Methacrylate
- 8.1.1 Overview
- 8.1.2 Polymethyl Methacrylate: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Polyether Ether Ketone
- 8.2.1 Overview
- 8.2.2 Polyether Ether Ketone: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Titanium
- 8.3.1 Overview
- 8.3.2 Titanium: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Cranial Implants Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Trauma Centers
- 9.2.1 Overview
- 9.2.2 Trauma Centers: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Cranial Implants Market - Country Analysis

10.1 South & Central America
- 10.1.1 South & Central America Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South & Central America Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Brazil: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Brazil: South & Central America Cranial Implants Market Share - by Type
    - 10.1.1.2.2 Brazil: South & Central America Cranial Implants Market Share - by Material
    - 10.1.1.2.3 Brazil: South & Central America Cranial Implants Market Share - by End User
  - 10.1.1.3 Argentina: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Argentina: South & Central America Cranial Implants Market Share - by Type
    - 10.1.1.3.2 Argentina: South & Central America Cranial Implants Market Share - by Material
    - 10.1.1.3.3 Argentina: South & Central America Cranial Implants Market Share - by End User
  - 10.1.1.4 Rest of South & Central America: South & Central America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 Rest of South & Central America: South & Central America Cranial Implants Market Share - by Type
    - 10.1.1.4.2 Rest of South & Central America: South & Central America Cranial Implants Market Share - by Material
    - 10.1.1.4.3 Rest of South & Central America: South & Central America Cranial Implants Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Product Launch
11.4 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Stryker Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Integra LifeSciences Holdings Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 OsteoMed SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Anatomics Pty Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Matrix Surgical Holdings LLC
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Calavera Surgical
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Xilloc Medical BV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Johnson & Johnson
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 evonos GmbH & Co. KG
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 B Braun SE
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 UAB Ortho Baltic
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 3D Systems Corp
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 GPC Medical Ltd
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Bioplate Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 EUROS SAS
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments
12.18 Biocomposites Ltd
- 12.18.1 Key Facts
- 12.18.2 Business Description
- 12.18.3 Products and Services
- 12.18.4 Financial Overview
- 12.18.5 SWOT Analysis
- 12.18.6 Key Developments
12.19 Medprin Biotech GmbH
- 12.19.1 Key Facts
- 12.19.2 Business Description
- 12.19.3 Products and Services
- 12.19.4 Financial Overview
- 12.19.5 SWOT Analysis
- 12.19.6 Key Developments
12.20 Kelyniam Global Inc
- 12.20.1 Key Facts
- 12.20.2 Business Description
- 12.20.3 Products and Services
- 12.20.4 Financial Overview
- 12.20.5 SWOT Analysis
- 12.20.6 Key Developments
12.21 MedCAD
- 12.21.1 Key Facts
- 12.21.2 Business Description
- 12.21.3 Products and Services
- 12.21.4 Financial Overview
- 12.21.5 SWOT Analysis
- 12.21.6 Key Developments
12.22 KLS Martin Group
- 12.22.1 Key Facts
- 12.22.2 Business Description
- 12.22.3 Products and Services
- 12.22.4 Financial Overview
- 12.22.5 SWOT Analysis
- 12.22.6 Key Developments
12.23 Longeviti Neuro Solutions LLC
- 12.23.1 Key Facts
- 12.23.2 Business Description
- 12.23.3 Products and Services
- 12.23.4 Financial Overview
- 12.23.5 SWOT Analysis
- 12.23.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms for Cranial Implant Market